Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
0(0%)
Results Posted
67%(2 trials)

Phase Distribution

Ph not_applicable
1
25%
Ph phase_4
3
75%

Phase Distribution

0

Early Stage

0

Mid Stage

3

Late Stage

Phase Distribution4 total trials
Phase 4Post-market surveillance
3(75.0%)
N/ANon-phased studies
1(25.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

4

all time

Status Distribution
Completed(3)
Terminated(1)

Detailed Status

Completed3
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
4
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 43 (75.0%)
N/A1 (25.0%)

Trials by Status

withdrawn125%
completed375%

Recent Activity

0 active trials
Showing 4 of 4
withdrawnphase_4

Recommendations for Monitoring Clinical Experience Following Implantation of the AcrySof® Toric

NCT00761488
completednot_applicable

Reduction of Corneal Astigmatism With Toric Intraocular Lens Implantation in Congenital Cataract

NCT02040129
completedphase_4

Visual Function After Implantation of Bilateral AcrySof® Toric Natural Intraocular Lens

NCT00760487
completedphase_4

Visual Function After Bilateral Implantation of AcrySof® Toric

NCT00758550

Clinical Trials (4)

Showing 4 of 4 trials
NCT00761488Phase 4

Recommendations for Monitoring Clinical Experience Following Implantation of the AcrySof® Toric

Withdrawn
NCT02040129Not Applicable

Reduction of Corneal Astigmatism With Toric Intraocular Lens Implantation in Congenital Cataract

Completed
NCT00760487Phase 4

Visual Function After Implantation of Bilateral AcrySof® Toric Natural Intraocular Lens

Completed
NCT00758550Phase 4

Visual Function After Bilateral Implantation of AcrySof® Toric

Completed

All 4 trials loaded

Drug Details

Intervention Type
DEVICE
Total Trials
4